Search by Drug Name or NDC
NDC 47426-0301-02 ZYNRELEF 400; 12 mg/14mL; mg/14mL Details
ZYNRELEF 400; 12 mg/14mL; mg/14mL
ZYNRELEF is a INFILTRATION SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heron Therapeutics, Inc.. The primary component is BUPIVACAINE; MELOXICAM.
Product Information
NDC | 47426-0301 |
---|---|
Product ID | 47426-301_ecef2459-9a3e-4a90-b95b-75b94ead9cf1 |
Associated GPIs | 66109902102040 |
GCN Sequence Number | 082297 |
GCN Sequence Number Description | bupivacaine/meloxicam SOLER VIAL 400-12/14 IMPLANT |
HIC3 | H0A |
HIC3 Description | LOCAL ANESTHETICS |
GCN | 49673 |
HICL Sequence Number | 047376 |
HICL Sequence Number Description | BUPIVACAINE/MELOXICAM |
Brand/Generic | Brand |
Proprietary Name | ZYNRELEF |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | BUPIVACAINE and MELOXICAM |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | INFILTRATION |
Active Ingredient Strength | 400; 12 |
Active Ingredient Units | mg/14mL; mg/14mL |
Substance Name | BUPIVACAINE; MELOXICAM |
Labeler Name | Heron Therapeutics, Inc. |
Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA211988 |
Listing Certified Through | 2024-12-31 |
Package
NDC 47426-0301-02 (47426030102)
NDC Package Code | 47426-301-02 |
---|---|
Billing NDC | 47426030102 |
Package | 1 CARTON in 1 KIT (47426-301-02) / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-301-04) / 14 mL in 1 VIAL, SINGLE-DOSE (47426-301-06) |
Marketing Start Date | 2021-07-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |